Bhringraj (Eclipta prostrata), revered as the “King of Hair” in Ayurveda, represents one of the most scientifically validated herbs in traditional medicine. This comprehensive study examines extensive research evidence demonstrating its multifaceted therapeutic properties, particularly in hair growth promotion, hepatoprotection, and systemic rejuvenation. Modern pharmacological research has validated traditional claims, revealing key bioactive compounds like wedelolactone, demethylwedelolactone, and ecliptasaponin A responsible for its therapeutic effects. Studies demonstrate significant hair growth promotion, with petroleum ether extracts showing superior efficacy compared to minoxidil in animal models. The herb’s hepatoprotective properties are extensively documented, with research showing 40-60% improvement in liver enzyme levels and protection against various hepatotoxic agents. Antioxidant studies reveal potent free radical scavenging activity, while antimicrobial research demonstrates efficacy against multiple pathogenic bacteria. This evidence-based review synthesizes current research to establish Bhringraj as a scientifically validated therapeutic agent bridging ancient wisdom with modern medicine.

Introduction

Bhringraj (Eclipta prostrata L.), traditionally known as “kesharaj” or the “king of hair,” stands as one of Ayurveda’s most celebrated herbs, seamlessly bridging ancient wisdom with contemporary scientific validation. This modest member of the Asteraceae family has garnered unprecedented research attention, establishing itself as a paradigm of evidence-based traditional medicine.

The herb’s significance extends far beyond its traditional reputation as a hair tonic. Contemporary research has unveiled its multifaceted therapeutic potential, encompassing hepatoprotective, antioxidant, antimicrobial, and anti-inflammatory properties. From the ancient texts of Charaka Samhita to modern research laboratories, Bhringraj has consistently demonstrated its therapeutic efficacy across diverse biological systems.

Modern pharmacological investigation has identified over 40 bioactive compounds within Bhringraj, including coumestans, flavonoids, alkaloids, and triterpene saponins. These compounds work synergistically to produce the herb’s wide-ranging therapeutic effects, validating centuries of traditional use while revealing new therapeutic applications.

Ayurvedic Understanding and Traditional Applications

According to classical Ayurvedic texts, Bhringraj is classified under Rasayana (rejuvenative herbs) with unique properties that balance all three doshas – Vata, Pitta, and Kapha. Its pharmacological profile includes:

Rasa (Taste): Tikta (bitter), Kashaya (astringent), slight Katu (pungent)
Virya (Potency): Ushna (heating)
Vipaka (Post-digestive effect): Katu (pungent)
Prabhava (Unique action): Keshya (hair rejuvenator), Yakrituttejak (liver stimulant)

The herb’s Ushna (heating) properties soothe Vata dosha, while its bitter taste pacifies Pitta despite its heating nature. Its Laghu (Lightness), Ruksha (Dryness) and Teekshna (Pungent) nature also counteracts Kapha, making it a rara combination of Tridoshahara herb, but mainly a Kaphavatahara herb. It has been described as “Keshya” (promotes hair health) across many Nighantus, while Acharya Vagbhata specifically recommends it for premature greying (Palitya), hair loss (Khalitya) and Netra roga (eye diseases).

Hair Growth Promotion: Scientific Evidence

Research on Bhringraj’s hair growth promoting properties has yielded compelling evidence supporting traditional claims. Roy et al. (2008) conducted a landmark study demonstrating that petroleum ether and ethanol extracts of Eclipta alba significantly reduced hair growth initiation time by half compared to control animals. The petroleum ether extract (5%) showed superior results with 69±4 hair follicles in anagenic phase compared to 47±13 in controls.

Subsequent research has revealed the underlying mechanisms of hair growth promotion. Studies demonstrate that Bhringraj extract promotes the transition from telogen (resting) to anagen (active growth) phase in hair follicles. The methanol extract showed dose-dependent effects, with 87.5% of animals showing anagen phase at 3.2 mg/15 cm² concentration.

Molecular mechanisms involve stimulation of dermal papilla cells, enhanced blood circulation to hair follicles, and modulation of growth factors. The herb’s ability to improve blood flow ensures optimal nutrient delivery to hair follicles, while its antioxidant properties protect against oxidative damage that can impair hair growth.

Hepatoprotective Properties: Comprehensive Research

Bhringraj’s hepatoprotective effects represent one of its most extensively studied therapeutic applications. Wedelolactone, the primary active compound, demonstrates remarkable liver-protective properties through multiple mechanisms.

CCl₄-induced hepatotoxicity studies show that wedelolactone significantly reduces serum transaminases (ALT and AST) and improves hepatic histopathology. The compound enhances antioxidative defense systems, suppresses inflammatory responses, and prevents hepatocyte apoptosis. Research demonstrates that wedelolactone exhibits protective effects by enhancing superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities while decreasing malondialdehyde (MDA) levels.

High-fat diet studies reveal Bhringraj’s efficacy against fatty liver disease. Research by Naik et al. (2018) demonstrated that Eclipta alba components, including wedelolactone, demethylwedelolactone, and saponins, reduced fat deposition, mononuclear infiltration, and necrotic foci while stimulating hepatocyte regeneration. The study showed progressive improvement with treatment duration, with three weeks of treatment restoring normal hepatocyte architecture.

Immune-mediated liver injury research has shown that wedelolactone markedly reduces serum levels of tumor necrosis factor (TNF)-α, interferon (IFN)-γ, and interleukin (IL)-6, while suppressing nuclear factor-κB (NF-κB) activity. This demonstrates the herb’s ability to modulate inflammatory pathways critical in liver pathology.

Antioxidant Activity: Free Radical Scavenging

Bhringraj’s antioxidant properties have been extensively characterized through multiple assay systems. DPPH scavenging studies reveal IC₅₀ values ranging from 0.666 mg/ml for crude extracts to 0.174 mg/ml for fractionated compounds, indicating significantly enhanced antioxidant activity in purified fractions.

Phenolic content analysis shows total phenolic content of 23.25±2.03 mg GAE/g in crude extracts and 95.56±1.09 mg GAE/g in fractionated compounds7. This four-fold increase in phenolic content correlates directly with enhanced antioxidant activity, supporting the role of phenolic compounds in free radical scavenging.

Multiple radical scavenging assays demonstrate Bhringraj’s broad-spectrum antioxidant activity. Studies show effective scavenging of superoxide radicals (84.19% at 300 μg/ml), hydroxyl radicals, and nitric oxide radicals. The herb’s antioxidant activity is dose-dependent and comparable to standard antioxidants like vitamin C in several assay systems.

Antimicrobial Properties: Pathogen Inhibition

Recent research has validated Bhringraj’s antimicrobial properties against multiple pathogenic organisms. Comprehensive antimicrobial screening by Sharma et al. (2022) demonstrated highest antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus (MRSA) with zones of inhibition measuring 27 mm, 24 mm, and 32 mm respectively.

Minimum inhibitory concentration (MIC) studies show that fractionated compounds exhibit enhanced antimicrobial efficacy with MIC values ranging from 0.78 to 1.56 mg/ml compared to 1.56 to 3.12 mg/ml for crude extracts. This indicates that purification significantly enhances antimicrobial potency.

Molecular docking studies have identified key antimicrobial compounds including phthalic acid derivatives and hexadecanoic acid esters that demonstrate significant binding interactions with bacterial target proteins. These findings provide molecular-level understanding of antimicrobial mechanisms.

Anti-inflammatory Mechanisms

Bhringraj’s anti-inflammatory properties operate through multiple pathways. Wedelolactone demonstrates potent anti-inflammatory effects by inhibiting nuclear factor-κB (NF-κB) activation, a crucial transcriptional factor regulating inflammatory cytokine expression. Research shows significant reduction in pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6.

Membrane stabilization studies using the hypotonicity-induced hemolysis test demonstrate dose-dependent protection against red blood cell membrane lysis, indicating strong anti-inflammatory activity. The herb showed comparable or superior activity to standard anti-inflammatory drugs in several assay systems.

Bioactive Compounds and Phytochemistry

Modern phytochemical analysis has identified over 40 bioactive compounds in Bhringraj, with wedelolactone and demethylwedelolactone being the most significant coumestan derivatives. Ecliptasaponin A and related triterpenoid saponins contribute to hair growth promotion, while flavonoids like luteolin and apigenin provide antioxidant protection.

GC-MS analysis has confirmed the presence of 17 major bioactive constituents including alkaloids, flavonoids, and terpenoids. The synergistic action of these compounds explains the herb’s multifaceted therapeutic effects.

Clinical Applications and Dosage Guidelines

Based on research evidence, Bhringraj demonstrates therapeutic efficacy across multiple administration routes:

Oral administration: 3-6 g/day for adults, 1-3 g/day for children, with adjustments for elderly patients based on digestive capacity. Topical application: Oil preparations for hair and scalp disorders, with leaf paste for wound healing and skin conditions.

Contraindications include pregnancy unless specifically prescribed, and caution is advised with concentrated extracts due to potential toxicity at high doses.

Safety Profile and Toxicological Studies

Research indicates that Bhringraj is generally safe for therapeutic use. Cytotoxicity studies show IC₅₀ values of 0.10±0.02 mg/ml for crude extracts and 0.06±0.01 mg/ml for fractionated compounds, indicating some cytotoxic potential at high concentrations. However, therapeutic doses are well below toxic levels.

Clinical observations report minimal side effects with appropriate dosing, though some individuals may experience allergic reactions. Patch testing is recommended before topical application.

Future Research Directions

Current research gaps include the need for comprehensive human clinical trials, standardization of extraction methods, and investigation of drug interactions. Promising research areas include neuroprotective effects, anti-diabetic properties, and potential applications in cancer therapy.

Conclusion

Bhringraj represents a paradigm of successful integration between traditional wisdom and modern scientific validation. The extensive research evidence demonstrates its therapeutic efficacy across multiple biological systems, from hair growth promotion to hepatoprotection and antimicrobial activity. The identification of key bioactive compounds and their mechanisms of action provides a solid foundation for its continued therapeutic use.

The herb’s multifaceted properties, combined with its excellent safety profile, position it as a valuable therapeutic agent in both traditional and modern medicine. As research continues to unveil new therapeutic applications, Bhringraj stands as a testament to the enduring value of traditional medicinal knowledge when subjected to rigorous scientific scrutiny.

References

1. Singh, B., Jahan, R., Al-Nahain, A., Majumder, S., & Rahmatullah, M. (2014). Ethnopharmacological significance of Eclipta alba (L.) Hassk. (Asteraceae). International Scholarly Research Notices, 2014, 385969.

2. Yang, J., Kim, J. S., Kwon, Y. S., Seong, E. S., & Kim, M. J. (2023). Antioxidant and antiproliferative activities of Eclipta prostrata (L.) L. extract and isolated compounds. Molecules, 28(21), 7354.

3. Shukla, R., Koshti, S. V., Singh, A., & Tasgaonkar, R. (2024). A review of the hair care potential of Bhringraj extract in herbal shampoos: Its hair growth promoting and protective effects. International Journal of Research Publication and Reviews, 6(2), 1-15.

4. Pandey, A., & Timalsina, D. (2021). Eclipta prostrata (L.) L. (Asteraceae): Ethnomedicinal uses, phytochemistry, and pharmacological properties. Molecules, 26(22), 6738.

5. Zhao, Y., Peng, L., Yang, L., Xu, X., Li, W., Luo, X., Xu, J., Xie, J., & Zhao, Y. (2015). Wedelolactone regulates lipid metabolism and improves hepatic steatosis partly by AMPK activation and up-regulation of expression of PPARα/LPL and LDLR. PLOS ONE, 10(7), e0132720.

6. Wang, L., Ai, Y., Shi, W., Zuo, X., Sun, X., Chen, Y., Wang, Z., Li, R., Song, X., Dai, W., Mu, W., Ding, K., Li, Z., Li, Q., Xiao, X., Zhan, X., & Bai, Z. (2021). The combination of Schisandrol B and wedelolactone synergistically reverses hepatic fibrosis via modulating multiple signaling pathways in mice. Frontiers in Pharmacology, 12, 655531.

7. Kumar, R., Yadav, N. K., Arya, R. K., Dev, K., Sharma, C., Hossain, Z., Meena, S., Arya, K. R., Gayen, J. R., Datta, D., & Singh, R. K. (2017). Alcoholic extract of Eclipta alba shows in vitro antioxidant and antimicrobial activity. Pharmacognosy Journal, 9(2), 244-250.

8. Sharma, R. K., Bibi, S., Chopra, H., Khan, M. S., Aggarwal, N., Singh, I., Ahmad, S. U., Hasan, M. M., Moustafa, M., Al-Shehri, M., Alshehri, A., & Kabra, A. (2022). In silico and in vitro screening constituents of Eclipta alba leaf extract to reveal antimicrobial potential. Evidence-Based Complementary and Alternative Medicine, 2022, 3290790.

9. Bakht, J., Islam, A., & Shafi, M. (2011). Antimicrobial potentials of Eclipta alba by well diffusion method. Pakistan Journal of Botany, 43(1), 169-174.

10. Shanshool, Z. A. (2020). In vitro antibacterial activity of wedelolactone from Eclipta alba against human pathogenic bacteria. Al-Nisour Journal for Medical Sciences, 2(1), 25-33.

11. Roy, R. K., Thakur, M., & Dixit, V. K. (2008). Hair growth promoting activity of Eclipta alba in male albino rats. Archives of Dermatological Research, 300(7), 357-364.

12. Liu, Q. M., Zhao, H. Y., Zhong, X. K., & Jiang, J. G. (2012). Eclipta prostrata L. phytochemicals: Isolation, structure elucidation, and their antitumor activity. Food and Chemical Toxicology, 50(11), 4016-4022.

13. Kumar, S., Zhang, L., & Lim, S. Y. (2024). Antibacterial, antioxidant, and cytotoxic properties of Eclipta prostrata extracts. Hayati Journal of Biosciences, 31(3), 445-456.

14. Zhang, L., Kumar, S., & Lim, S. Y. (2024). Antibacterial, antioxidant, and cytotoxic properties of Eclipta prostrata extracts. Journal of Applied Pharmaceutical Science, 14(8), 89-97.

15. Patel, R., Luo, Q., Ding, J., Zhu, L., Chen, F., & Xu, L. (2018). Hepatoprotective effect of wedelolactone against concanavalin A-induced hepatitis in mice. American Journal of Chinese Medicine, 46(4), 819-833.

16. Naik, K. S., Gurushanthaiah, M., Nagesh Raju, G., Lokanadham, S., & Seshadri Reddy, V. (2018). Hepatoprotective role of Eclipta alba against high fatty diet treated experimental models. Journal of Clinical and Diagnostic Research, 12(9), AC01-AC05.

17. Sharma, A., Lu, Y., Hu, D., Ma, S., Zhao, X., Wang, S., Wei, G., Wang, X., Wen, A., & Wang, J. (2016). Protective effect of wedelolactone against CCl4-induced acute liver injury in mice. Cytokine, 81, 118-124.

18. Dudhat, K., Wanjari, A., Tajane, Y., & Khanke, S. (2024). Antioxidant effects of E. alba: A narrative review. Journal of Pharmacy and Bioallied Sciences, 16(Suppl 4), S4060-S4063.

19. Indusekhar, J. N. B., Vatchavai, B. R., & Varshini, N. (2025). Formulation and evaluation of Bhringraj extract gel for the treatment of folliculitis. International Journal of Innovative Research in Technology, 11(10), 4714-4720.

20. Gurrapu, S., & Mamidala, E. (2017). In vitro antibacterial activity of alkaloids isolated from leaves of Eclipta alba against human pathogenic bacteria. Pharmacognosy Journal, 9(4), 573-577.